"## AMRrules specification v0.6, file updated 2025-09-03"																							
ruleID	txid	organism	gene	nodeID	protein accession	HMM accession	nucleotide accession	ARO accession	mutation	variation type	gene context	drug	drug class	phenotype	clinical category	breakpoint	breakpoint standard	breakpoint condition	PMID	evidence code	evidence grade	evidence limitations	rule curation note
ECC001	158836	s__Enterobacter hormaechei	blaACT	blaACT	-	NF000385.4	-	ARO:3000072	-	Gene presence detected	core	amoxicillin	-	wildtype	R	MIC >=8 mg/L	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0001091 knockout phenotypic evidence"	high	-	
ECC002	158836	s__Enterobacter hormaechei	blaACT	blaACT	-	NF000385.4	-	ARO:3000072	-	Gene presence detected	core	amoxicillin-clavulanic acid	-	wildtype	R	MIC >=8 mg/L	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0001091 knockout phenotypic evidence"	moderate	lacks evidence of the degree to which MIC is affected	
ECC003	158836	s__Enterobacter hormaechei	blaACT	blaACT	-	NF000385.4	-	ARO:3000072	-	Gene presence detected	core	ampicillin	-	wildtype	R	MIC >=8 mg/L	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0001091 knockout phenotypic evidence"	high	-	
ECC004	158836	s__Enterobacter hormaechei	blaACT	blaACT	-	NF000385.4	-	ARO:3000072	-	Gene presence detected	core	-	first-generation cephalosporin	wildtype	R	not applicable	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0000012 functional complementation evidence"	high	-	
ECC005	158836	s__Enterobacter hormaechei	blaACT	blaACT	-	NF000385.4	-	ARO:3000072	-	Gene presence detected	core	-	second-generation cephalosporin	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0001091 knockout phenotypic evidence"	high	-	
ECC006	158836	s__Enterobacter hormaechei	blaACT	blaACT	-	NF000385.4	-	ARO:3000072	-	Gene presence detected	core	cefuroxime	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	35934231	ECO:0001103 natural variation mutant evidence	high	-	
ECC007	158836	s__Enterobacter hormaechei	blaACT	blaACT	-	NF000385.4	-	ARO:3000072	-	Gene presence detected	core	cefoxitin	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	35934231	ECO:0001103 natural variation mutant evidence	high	-	
ECC008	158836	s__Enterobacter hormaechei	oqxA	oqxA	-	NF000272.1	-	ARO:3003922	-	Gene presence detected	core	-	fluoroquinolone antibiotic	wildtype	S	not applicable	EUCAST v15.0 (2025)	-	25801572	ECO:0001103 natural variation mutant evidence	high	-	
ECC009	158836	s__Enterobacter hormaechei	oqxB	oqxB	-	NF000037.1	-	ARO:3003923	-	Gene presence detected	core	-	fluoroquinolone antibiotic	wildtype	S	not applicable	EUCAST v15.0 (2025)	-	25801572	ECO:0001103 natural variation mutant evidence	high	-	
ECC010	158836	s__Enterobacter hormaechei	fosA	fosA	WP_038415208.1	-	-	ARO:3000149	-	Gene presence detected	core	fosfomycin	-	wildtype	-	not available	EUCAST v15.0 (2025)	-	28851843	ECO:0001103 natural variation mutant evidence	low	low clinical relevance	"There are no clinical breakpoints established for fosfomycin in Enterobacterales other than E. coli, as there is a lack of clinical evidence. The ECOFF has not yet been defined due the lack of  enough MIC data determined with the reference method  The breakpoint for E. coli (UTI only) is 8 mg/L. Enterobacter hormaechei carrying this gene have MICs in the range 8-128 mg/L."
ECC011	1812935	s__Enterobacter roggenkampii	blaMIR	blaMIR	-	NF000187.3	-	ARO:3000058	-	Gene presence detected	core	amoxicillin	-	wildtype	R	MIC >=8 mg/L	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0001091 knockout phenotypic evidence"	high	-	
ECC012	1812935	s__Enterobacter roggenkampii	blaMIR	blaMIR	-	NF000187.3	-	ARO:3000058	-	Gene presence detected	core	amoxicillin-clavulanic acid	-	wildtype	R	MIC >=8 mg/L	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	ECO:0001103 natural variation mutant evidence	moderate	lacks evidence of the degree to which MIC is affected	
ECC013	1812935	s__Enterobacter roggenkampii	blaMIR	blaMIR	-	NF000187.3	-	ARO:3000058	-	Gene presence detected	core	ampicillin	-	wildtype	R	MIC >=8 mg/L	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0001091 knockout phenotypic evidence"	high	-	
ECC014	1812935	s__Enterobacter roggenkampii	blaMIR	blaMIR	-	NF000187.3	-	ARO:3000058	-	Gene presence detected	core	-	first-generation cephalosporin	wildtype	R	not applicable	"EUCAST v15.0 (2025), EUCAST Expected resistant phenotypes v1.2 (2023)"	-	35934231	ECO:0001103 natural variation mutant evidence	high	-	
ECC015	1812935	s__Enterobacter roggenkampii	blaMIR	blaMIR	-	NF000187.3	-	ARO:3000058	-	Gene presence detected	core	cefuroxime	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	35934231	"ECO:0001103 natural variation mutant evidence, ECO:0000012 functional complementation evidence"	high	-	
ECC016	1812935	s__Enterobacter roggenkampii	blaMIR	blaMIR	-	NF000187.3	-	ARO:3000058	-	Gene presence detected	core	cefoxitin	-	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	35934231	ECO:0001103 natural variation mutant evidence	high	-	
ECC017	1812935	s__Enterobacter roggenkampii	blaMIR	blaMIR	-	NF000187.3	-	ARO:3000058	-	Gene presence detected	core	-	second-generation cephalosporin	wildtype	R	not applicable	EUCAST Expected resistant phenotypes v1.2 (2023)	-	35934231	ECO:0001103 natural variation mutant evidence	high	-	
ECC018	1812935	s__Enterobacter roggenkampii	oqxA	oqxA	-	NF000272.1	-	ARO:3003922	-	Gene presence detected	core	-	fluoroquinolone antibiotic	wildtype	S	not applicable	EUCAST v15.0 (2025)	-	25801572	ECO:0001103 natural variation mutant evidence	high	-	
ECC019	1812935	s__Enterobacter roggenkampii	oqxB	oqxB	-	NF000037.1	-	ARO:3003923	-	Gene presence detected	core	-	fluoroquinolone antibiotic	wildtype	S	not applicable	EUCAST v15.0 (2025)	-	25801572	"ECO:0001103 natural variation mutant evidence, ECO:0000012 functional complementation evidence"	high	-	
ECC020	1812935	s__Enterobacter roggenkampii	fosA	fosA	WP_038415208.1	-	-	ARO:3000149	-	Gene presence detected	core	fosfomycin	-	wildtype	-	not available	EUCAST v15.0 (2025)	-	28851843	"ECO:0001103 natural variation mutant evidence, ECO:0000024 protein-binding evidence"	low	low clinical relevance	"There are no clinical breakpoints established for fosfomycin in Enterobacterales other than E. coli, as there is a lack of clinical evidence. The ECOFF has not yet been defined due the lack of enough MIC data determined with the reference method.  The breakpoint for E. coli (UTI only) is 8 mg/L. Enterobacter hormaechei carrying this gene have MICs in the range 8-128 mg/L."